iPS Academia Japan | GenomeWeb

iPS Academia Japan

NEW YORK (GenomeWeb News) – Life Technologies today announced a worldwide, non-exclusive deal with iPS Academia Japan for its induced pluripotent stem cell patent portfolio.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cellular Dynamics today announced it has expanded its distribution deal with iPS Academia Japan to include iCell Neurons and iCell Endothelial Cells.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has licensed worldwide rights to Kyoto University's induced pluripotent stem cell patent portfolio.

iPS Academia Japan will distribute the firm's iCell Cardiomyocytes in Japan.

The French firm licensed non-exclusive rights to certain patents covering research conducted by Shinya Yamanaka of the Center for iPS Cell Research and Application at Kyoto University in Japan.

Cellular Dynamics and iPS Academia Japan announced a non-exclusive licensing agreement giving CDI access to an induced pluripotent stem cell portfolio based on research done by Kyoto University researcher Shinya Yamanaka.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.